These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18549919)

  • 21. B-type natriuretic peptide in the evaluation of acute dyspnea.
    Martinez-Selles M
    N Engl J Med; 2004 Jun; 350(23):2416-7; author reply 2416-7. PubMed ID: 15175447
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessing prognosis in heart failure: is hepatocyte growth factor the next B-type natriuretic peptide?
    Katz JN; Drazner MH
    Am Heart J; 2005 Jul; 150(1):1-3. PubMed ID: 16084142
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in heart failure: natriuretic peptide testing.
    Rehman SU; Januzzi JL
    Panminerva Med; 2008 Jun; 50(2):139-51. PubMed ID: 18607337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
    Maisel A
    J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
    [No Abstract]   [Full Text] [Related]  

  • 25. [B-type natriuretic peptide as a prognostic marker in heart failure].
    Yasumura Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():300-3. PubMed ID: 17569316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasma brain natriuretic peptide as a useful biomarker of heart failure].
    Tsutamoto T; Horie M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():417-25. PubMed ID: 17508576
    [No Abstract]   [Full Text] [Related]  

  • 27. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of B-type natriuretic peptide test.
    Grauer K
    J Fam Pract; 2003 Apr; 52(4):310; author reply 310. PubMed ID: 12718325
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognosis in heart failure with a normal ejection fraction.
    Cleland JG; Taylor J; Tendera M
    N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
    [No Abstract]   [Full Text] [Related]  

  • 31. New methods in laboratory diagnostics of dilated cardiomyopathy.
    Bielecka-Dabrowa A; Wierzbicka M; Dabrowa M; Goch A
    Cardiol J; 2008; 15(4):388-95. PubMed ID: 18698552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain natriuretic peptide in heart failure: an improving prognosis?
    Crook D; Smith H
    Eur Heart J; 2005 Jun; 26(11):1052-3. PubMed ID: 15800016
    [No Abstract]   [Full Text] [Related]  

  • 33. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Present and future of BNP].
    Yoshimura M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():147-50. PubMed ID: 15506359
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation.
    Taub PR; Daniels LB; Maisel AS
    Heart Fail Clin; 2009 Apr; 5(2):169-75. PubMed ID: 19249686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BNP: not just for heart failure.
    Nicholls MG; Frampton CM; Yandle TG
    Heart; 2008 Jan; 94(1):6-7. PubMed ID: 18083945
    [No Abstract]   [Full Text] [Related]  

  • 37. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath].
    Bayés-Genís A
    Rev Esp Cardiol; 2005 Oct; 58(10):1142-4. PubMed ID: 16238980
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.